Articles with category: Article
Mythbusters: It sounds too much
Estimated values of seized drugs can be mind-bogglingly huge. But are these estimates accurate reflections of the likely street value?
About a drug: Alpha-PVP
Alpha-pyrrolidinovalerophenone is one of a number of recreational drugs in the 'bath salts' (cathinones) family, so called because they resemble bath salts and have sometimes been sold disguised as such.
Q&A: Toni-Marie Matich
Toni-Marie Matich is the co-founder of the NZ branch of United in Compassion, set up to advocate for the introduction of medicinal cannabis.
Guest editorial: Alcohol advertising: what's the problem?
While advertising of alcohol keeps spreading and spreading, the industry denies this leads to more harms. The evidence says otherwise.
Viewpoints: Should we be concerned about rising PIED use?
Use of performance and image-enhancing drugs is on the rise in NZ - that may be a cause for concern.
Opinion: A brave, new drug policy
The National Drug Policy 2015-2020 is finally out. How does it stack up? Drug Foundation Principal Policy Advisor Andrew Zielinski looks at the pros and cons.
A school's core business
This is the second in our Whole School Series, which look into new approaches to protecting young people from drug-related harm being adopted by NZ schools.
The cruel 'C'
The outlook for those suffering from hepatitis C is pretty bleak. Russell Brown looks at the NZ situation and some encouraging developments overseas.
Taking the pulse of Māori public health
Restoring equality and addressing health outcomes for Māori come with many challenges. Matt Calman talks with four figures from the sector about treatment and harm reduction.
Mythbusters: Is cannabis really 100 times safer than alcohol?
There are many factors to consider when assessing drug-related harm. Claiming that cannabis is 114 times safer than alcohol is, like some of the data in a recent study, very uncertain.
About a drug: Dabbing and BHO
Dabbing is a relatively new way of smoking cannabis involving highly concentrated extracts known as BHO (short for either ’butane honey oil’ or ’butane hash oil’).
Q&A: Beau Kilmer
Before Beau Kilmer's keynote address at the Australasian Drug and Alcohol Strategy Conference in Brisbane, we invited the RAND Corporation researcher to visit the Drug Foundation.